Human EMR data The population of semaglutide and tirzepatide users was selected according to Rodriguez et al., 2024 and a data snapshot created 1/27/2025
Semaglutide represents a significant advancement in the pharmacological treatment of type 2 diabetes and obesity, not only due to its efficacy but also because of its versatile administration routes
Wegovy is available in two forms, as a once-daily oral pill or a once-weekly injection
For weight loss, semaglutide makes you feel less hungry and slows gastric emptying, or how fast food leaves your stomach
However, conclusive evidence supporting these claims remains limited, and more extensive research is needed to substantiate these purported benefits comprehensively
PlexusDx also offers an optional Precision Peptide Genetic Test ($298) to identify genetic factors influencing your response to tirzepatide and GI side effect risk